Artiva Biotherapeutics, Inc. (ARTV)
Nasdaq: ARTV · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 10, 2026 | Mar 24, 2025 | · |
| Revenue | 0 | 251 | 33,492 |
| Research and development | 69,540 | 50,328 | 50,251 |
| General and administrative | 20,270 | 17,205 | 13,912 |
| Total operating expenses | 89,810 | 67,533 | 64,163 |
| Operating income | -89,810 | -67,282 | -30,671 |
| Interest and investment income | 5,959 | 5,349 | 2,535 |
| Other income (expense), net | -14 | 157 | 195 |
| Total non-operating income (expense) | 5,945 | 1,909 | 2,023 |
| Income before income taxes | · | -65,373 | -28,648 |
| Income tax expense | 0 | 0 | 72 |
| Net income | -83,865 | -65,373 | -28,720 |
| Earnings per share, basic | -3.43 | -5.81 | -35.78 |
| Earnings per share, diluted | -3.43 | -5.81 | -35.78 |
| Weighted average shares, basic | 24,444,057 | 11,258,851 | 802,747 |
| Weighted average shares, diluted | 24,444,057 | 11,258,851 | 802,747 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding